celecoxib · Carwin Pharm Assoc · NDA 211759
Vyscoxa
Earliest generic entry, as listed
17 Sep 2045
Blocked by patent: US 12678405.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12678405 | product | 17 Sep 2045 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 211759 · 001 · RLD | suspension, oral | 10MG/ML | 17 Sep 2045 |